Candriam SCA’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10
| Closed | -$3.8M | – | 821 |
|
|
2023
Q1 | $3.8M | Buy |
+10
| New | +$3.8M | 0.03% | 425 |
|
|
2022
Q2 | – | Sell |
-42
| Closed | -$2K | – | 811 |
|
|
2022
Q1 | $2K | Buy |
+42
| New | +$2K | ﹤0.01% | 791 |
|
|
2021
Q4 | – | Sell |
-46
| Closed | -$2K | – | 848 |
|
|
2021
Q3 | $2K | Sell |
46
-10
| -18% | -$435 | ﹤0.01% | 862 |
|
|
2021
Q2 | $2K | Sell |
56
-2
| -3% | -$71 | ﹤0.01% | 866 |
|
|
2021
Q1 | $2K | Buy |
58
+2
| +4% | +$69 | ﹤0.01% | 785 |
|
|
2020
Q4 | $2K | Buy |
56
+12
| +27% | +$429 | ﹤0.01% | 796 |
|
|
2020
Q3 | $2K | Sell |
44
-49,162
| -100% | -$2.23M | ﹤0.01% | 790 |
|
|
2020
Q2 | $1.61M | Buy |
49,206
+3,048
| +7% | +$99.8K | 0.02% | 523 |
|
|
2020
Q1 | $1.31M | Buy |
46,158
+94
| +0.2% | +$2.66K | 0.01% | 609 |
|
|
2019
Q4 | $1.33M | Buy |
+46,064
| New | +$1.33M | 0.01% | 627 |
|
|
2019
Q3 | – | Sell |
-84
| Closed | -$2.14M | – | 792 |
|
|
2019
Q2 | $2.14M | Buy |
84
+14
| +20% | +$357K | 0.03% | 501 |
|
|
2019
Q1 | $1.83M | Buy |
+70
| New | +$1.83M | 0.02% | 521 |
|